Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

Delayed Quote. Delayed  - 06/30 03:45:55 pm
79.7 CHF   -0.06%
06/29 NOVARTIS : PKC412 (midostaurin) pivotal data published in NEJM show ..
06/29 NOVARTIS : Land conservancy gets helping hands
06/29 NOVARTIS : Psoriasis survey reveals discrimination and low treatment..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/24/2016 06/27/2016 06/28/2016 06/29/2016 06/30/2016 Date
75.75(c) 75.35(c) 77.45(c) 79.75(c) 79.7 Last
10 564 523 6 246 004 7 224 621 6 626 160 2 809 834 Volume
-1.56% -0.53% +2.79% +2.97% -0.06% Change
More quotes
Financials ($)
Sales 2016 48 752 M
EBIT 2016 12 189 M
Net income 2016 7 585 M
Debt 2016 14 214 M
Yield 2016 3,50%
Sales 2017 50 351 M
EBIT 2017 13 393 M
Net income 2017 8 770 M
Debt 2017 12 120 M
Yield 2017 3,68%
P/E ratio 2016 23,47
P/E ratio 2017 21,13
EV / Sales2016 4,67x
EV / Sales2017 4,48x
Capitalization 213 353 M
More Financials
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines & Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers surgical,... 
Sector
Pharmaceuticals
Calendar
07/19Earnings Release
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
06/29 NOVARTIS : PKC412 (midostaurin) pivotal data published in NEJM show 60% response..
06/29 NOVARTIS : Land conservancy gets helping hands
06/29 NOVARTIS : Psoriasis survey reveals discrimination and low treatment expectation..
06/29 NOVARTIS : Largest global psoriasis survey shows 84% of people face discriminati..
06/28 NOVARTIS : and Xencor enter bispecific antibody collaboration
06/28 NOVARTIS : adds bispecific antibodies to its growing immuno-oncology portfolio t..
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/23 NOVARTIS : Sandoz Canada Concludes a New Collective Agreement With Unionized Emp..
06/23 NOVARTIS : Patent Issued for Sharp Fixation Target (USPTO 9364141)
06/23 NOVARTIS : Field Service Workers Represented by Nichols Kaster, PLLP and JTB Law..
More news
Sector news : Pharmaceuticals - NEC
09:13a ASTRAZENECA : *jefferies raises astrazeneca price target to 4450 pence - 'hold'
08:51aDJMONSANTO : Shops Around For 'Right Combination' -- WSJ
08:10a DAIICHI SANKYO : FTSE Russell Corporation Selects Daiichi Sankyo for FTSE4Good G..
08:01a OPKO HEALTH : to Acquire Transition Therapeutics
03:32aDJSHANGHAI FOSUN PHARMACEUTICAL () : Approves Listing of 66.2%-Owned Sisram Medica..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/29 BIOTECH FORUM DAILY DIGEST : Brexit Impacts Continue, Xencor's Huge Deal, Major ..
06/29 Novartis Turns To Xencor For CAR-T Backup
06/24 Eylea Combinations And Array's Play For Melanoma
06/23 Valuable Late-Stage Pipeline Sets 2017 Up For Some Big Events
06/20 REGENERON GENERATES NEGATIVE ALPHA : Buy, Sell Or Hold?
Advertisement
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions